These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6604284)

  • 1. Simultaneous in vitro and in vivo evaluation of both trimethoprim and sulfamethoxazole from certain dosage forms.
    Meshali M; El-Sabbagh H; Ghanem A; Foda A
    Pharmazie; 1983 Jun; 38(6):403-6. PubMed ID: 6604284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous solubility and dissolution rate of sulfamethoxazole and trimethoprim in binary mixture.
    Meshali M; el-Sabbagh H; Ramadan I
    Pharmazie; 1984 Jun; 39(6):407-8. PubMed ID: 6483946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance thin-layer chromatographic determination of trimethoprim and sulphamethoxazole in pharmaceutical dosage forms.
    Tammilehto SA
    J Chromatogr; 1985 Apr; 323(2):456-61. PubMed ID: 3873463
    [No Abstract]   [Full Text] [Related]  

  • 4. Solubilities and intrinsic dissolution rates of sulphamethoxazole and trimethoprim.
    Dahlan R; McDonald C; Sunderland VB
    J Pharm Pharmacol; 1987 Apr; 39(4):246-51. PubMed ID: 2884286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the dissolution and bioavailability of trimethoprim-sulfadiazine-sulfamethoxazole tablets].
    Shao J; Mao FF; Tu XD
    Yao Xue Xue Bao; 1992; 27(5):375-80. PubMed ID: 1442059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Trimethoprim--sulfonamide drug combinations in dosage forms by UV spectroscopy and liquid chromatography (HPLC).
    Bonazzi D; Andrisano V; Di Pietra AM; Cavrini V
    Farmaco; 1994 Jun; 49(6):381-6. PubMed ID: 8074781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption characteristics of sulfamethoxazole combined with trimethoprim].
    Cid E; Mella F; Retamal A
    Rev Med Chil; 1985 Jul; 113(7):673-7. PubMed ID: 3914026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spectrophotometry analysis, following thin-layer chromatographic separation, of the active ingredients sulfamethoxazole and trimethoprim in sumetrolim tablets].
    Vámos J; Kócziánné Földvári K; Szász G
    Acta Pharm Hung; 1986 Sep; 56(5):217-26. PubMed ID: 3492087
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in dosage forms.
    Singletary RO; Sancilio FD
    J Pharm Sci; 1980 Feb; 69(2):144-6. PubMed ID: 7359311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination trimethoprim-sulphamethoxazole.
    Hansen I
    Antibiot Chemother (1971); 1978; 25():217-32. PubMed ID: 352254
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extractive spectrophotometric determination of trimethoprim in a mixture with sulfamethoxazole].
    Vachek J; Kakac B
    Cesk Farm; 1976 Jun; 25(5):186-7. PubMed ID: 975259
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro absorption studies on trimethoprim and sulfamethoxazole note II.
    Caramella C; Giordano F; Bettinetti GP; Colombo P; Conte U; La Manna A; Gastaldi G; Casirola D; Ferrari G
    Pharm Acta Helv; 1983; 58(3):85-7. PubMed ID: 6601807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bioavailability of trimethoprim in different commercial products of co-trimoxazole].
    Cid E; Mella F; David J
    Rev Med Chil; 1984 Apr; 112(4):359-63. PubMed ID: 6333057
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions and physical properties in trimethoprim-sulfamethoxazole suspensions.
    Caramella C; Giordano F; Bettinetti GP; Colombo P; Conte U; La Manna A
    Farmaco Prat; 1980 Jun; 35(6):277-85. PubMed ID: 7449948
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relative clinical biological availability of a combination of trimethoprim-sulfamethoxazole in fasting children and after a meal].
    Guggenbichler JP; Takacs F
    Padiatr Padol; 1980; 15(4):305-20. PubMed ID: 7007989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation.
    Sun M; Sun J; He S; Wang Y; Sun Y; Liu X; He Z
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1099-106. PubMed ID: 22188158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension.
    Gupta KC; Desai NK; Satoskar RS; Gupta C; Goswami SN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):320-1. PubMed ID: 3497885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous spectrophotometric determination of trimethoprim and sulphamethoxazole in pharmaceutical preparations.
    Ghanem A; Meshali M; Foda A
    J Pharm Pharmacol; 1979 Feb; 31(2):122-3. PubMed ID: 33248
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of concentrated trimethoprim-sulfamethoxazole admixtures.
    Jarosinski PF; Kennedy PE; Gallelli JF
    Am J Hosp Pharm; 1989 Apr; 46(4):732-7. PubMed ID: 2785757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance analysis of pharmaceuticals. Part XV. Determination of sulfamethoxazole and trimethoprim in combination in tablets.
    Turczan JW
    Anal Chim Acta; 1977 Aug; 92(1):123-8. PubMed ID: 889104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.